Brief: Biocartis End-Dec Cash Position Amounts To EUR 53.5 Mln

Biocartis NV

10/01/2022 06:08

Jan 10 (Reuters) - Biocartis Group NV  BCART.BR :
    * ANNOUNCES IT MEETS 2021 KEY OBJECTIVES
    * 2021 KEY BUSINESS OBJECTIVES WHICH WERE FOCUSED ON THREE
PERFORMANCE INDICATORS: EXPANDED INSTALLED BASE OF ITS RAPID AND
EASY-TO-USE IDYLLA™ MOLECULAR DIAGNOSTICS PLATFORM, INCREASED
IDYLLA™ COMMERCIAL CARTRIDGE VOLUME AND ITS YEAR-END CASH
POSITION
    * PLACED 331 NET NEW IDYLLA™ INSTRUMENTS IN 2021
    * IN 2021, BIOCARTIS SOLD 323K COMMERCIAL CARTRIDGES, 40%
MORE
THAN IN 2020 AND IN LINE WITH THE LATEST GUIDANCE
    * AS PER 31 DECEMBER 2021, BIOCARTIS’ CASH POSITION AMOUNTED
TO
EUR 53.5M (NON-AUDITED NUMBER) VERSUS THE LATEST GUIDANCE OF EUR
50M

Source text for Eikon:  ID:nGNE4GKH3R 
Further company coverage:  BCART.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))